Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| CAC | PRESS-RELEASE | neutral | 1/10 | Camden National Corporation announced it will report its Q4 2026 results on October 27, 2026. | Oct 1, 2026 |
| FULT | PRESS-RELEASE | neutral | 1/10 | Fulton Financial Corporation announced it will report its Q3 2026 results on October 21. | Oct 1, 2026 |
| RCAT | PRESS-RELEASE | neutral | 3/10 | Red Cat Holdings announced a strategic partnership between its Blue Ops maritime division and Florida Atlantic Universit | Oct 1, 2026 |
| AB | PRESS-RELEASE | neutral | 1/10 | AllianceBernstein announced it will report its Q3 2026 results on October 27, 2026. | Oct 1, 2026 |
| BCO | PRESS-RELEASE | neutral | 2/10 | The Brink's Company declared a regular quarterly dividend of $0.255 per share, payable December 1, 2026. This is a routi | Oct 1, 2026 |
| REGN | PRESS-RELEASE | bullish | 6/10 | Regeneron announced first clinical data for ubamatamab (MUC16xCD3 bispecific) in low-grade serous ovarian cancer (LGSOC) | Oct 1, 2026 |
| REGN | PRESS-RELEASE | bullish | 6/10 | Regeneron announced positive Phase 2 COURAGE trial results for trevogrumab (anti-myostatin) showing preservation of lean | Oct 1, 2026 |
| TGL | PRESS-RELEASE | bullish | 5/10 | Treasure Global reported preliminary FY2026 revenue of ~$5.17M (+122% YoY) and a narrowed net loss of ~$11.1M (improved | Oct 1, 2026 |
| TXN | PRESS-RELEASE | neutral | 1/10 | Texas Instruments Incorporated announced it will host a conference call on October 21 to discuss its Q3 2026 results. | Oct 1, 2026 |
| STBA | PRESS-RELEASE | neutral | 1/10 | S&T Bancorp, Inc. announced it will host a conference call on October 22, 2026 to discuss its Q3 results. | Oct 1, 2026 |
| WTW | PRESS-RELEASE | neutral | 2/10 | Willis Towers Watson released its fall 2026 Insurance Marketplace Realities report, highlighting a continued softening i | Oct 1, 2026 |
| AAL | PRESS-RELEASE | neutral | 1/10 | American Airlines, Inc. announced it will host a conference call on October 22 to discuss its Q3 2026 results. | Oct 1, 2026 |
| HTO | PRESS-RELEASE | bullish | 6/10 | H2O America's Texas subsidiary completed the acquisition of all Quadvest assets, more than doubling its Texas water/wast | Oct 1, 2026 |
| MAN | PRESS-RELEASE | neutral | 1/10 | ManpowerGroup announced it will report its Q3 2026 results on October 15, 2026. | Oct 1, 2026 |
| BOSC | PRESS-RELEASE | neutral | 3/10 | BOSC's Intelligent Robotics Division received a $380,000 follow-on order from an existing Israeli defense customer for r | Oct 1, 2026 |
| UNIT | PRESS-RELEASE | neutral | 3/10 | Kinetic, a business unit of Uniti Group Inc., announced a strategic partnership with STL Optical Connectivity NA, LLC to | Oct 1, 2026 |
| GANX | PRESS-RELEASE | neutral | 4/10 | Gain Therapeutics presented Phase 1b open-label extension data for rexaceract (GT-02287) at the MDS Congress, showing MD | Oct 1, 2026 |
| QNME | PRESS-RELEASE | neutral | 4/10 | Quanome Technologies entered into a revolving loan agreement with CEO Yang Li for up to $15 million in non-dilutive grow | Oct 1, 2026 |
| ERNA | PRESS-RELEASE | neutral | 4/10 | Ernexa Therapeutics announced the appointment of Dr. Robert J. Spiegel to its Board of Directors and provided a pipeline | Oct 1, 2026 |
| BCDA | PRESS-RELEASE | bullish | 7/10 | BioCardia announced it has completed a revised De Novo pre-submission to the FDA's CDRH for its Helix Catheter, a device | Oct 1, 2026 |
| PYPD | PRESS-RELEASE | bullish | 7/10 | PolyPid announced that the EMA has validated its MAA for D-PLEX100, initiating formal regulatory review for EU approval. | Oct 1, 2026 |
| FNGR | PRESS-RELEASE | neutral | 4/10 | FingerMotion entered a binding agreement to acquire ~20.2 acres in Hanna, Alberta for a planned 6 MW AI inference campus | Oct 1, 2026 |
| CHE | PRESS-RELEASE | neutral | 1/10 | Chemed Corp. announced it will report its Q3 2026 results on October 28. | Oct 1, 2026 |
| BYD | PRESS-RELEASE | neutral | 1/10 | Boyd Gaming Corporation announced it will report its Q3 2026 results on October 22. | Oct 1, 2026 |
| PYPD | PRESS-RELEASE | mixed | 5/10 | PolyPid and ADVANZ PHARMA mutually terminated their 2022 exclusive European license agreement for D-PLEX₁₀₀, reverting E | Oct 1, 2026 |
| HSY | PRESS-RELEASE | neutral | 2/10 | The Hershey Company appointed Amanda Almond as President, International, effective Oct. 12, succeeding Rohit Grover afte | Oct 1, 2026 |
| QTEX | PRESS-RELEASE | bullish | 6/10 | QTREX Quantum announced independent cryogenic testing results showing its AME interconnect achieves >100 dB channel-to-c | Oct 1, 2026 |
| EMAT | PRESS-RELEASE | neutral | 3/10 | Evolution Metals & Technologies Corp. (EMAT) signed a non-binding letter of intent with VIVIFY Technology to deploy behi | Oct 1, 2026 |
| BATL | PRESS-RELEASE | neutral | 3/10 | Battalion Oil appointed John "Brad" Juneau as an independent director, expanding the board to five members. Juneau bring | Oct 1, 2026 |
| TOMZ | PRESS-RELEASE | neutral | 3/10 | TOMI Environmental Solutions announced growing adoption of its SteraMist iHP technology in India's pharmaceutical sector | Oct 1, 2026 |